Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut H Malluche

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Clinical Nephrology|October 6, 2022
Treatment of bone loss in CKD5D: Better survival in patients with non-high bone turnoverHartmut H Malluche, Daniel L Davenport, Marie-Claude Monier-Faugere, et al.
Endocrinology|June 18, 2003
Sp3/Sp1 in the parathyroid gland: identification of an Sp1 deoxyribonucleic acid element in the parathyroid hormone promoterAlexander P Alimov, M Chris Langub, Hartmut H Malluche, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 21, 2014
Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysisHartmut H Malluche, Daniel L Davenport, Tom Cantor, et al.
The Journal of Biological Chemistry|August 7, 2004
Suppression of the human parathyroid hormone promoter by vitamin D involves displacement of NF-Y binding to the vitamin D response elementNicholas J Koszewski, Alexander P Alimov, Ok-Kyong Park-Sarge, et al.
Clinical Nephrology|January 7, 2025
Kidney function, bone health, and vascular calcifications in patients with CKD II - IV: A 2 - 3 year prospective study with bone biopsiesHartmut H Malluche, Qi Qiao, Florence Lima, et al.
Clinical Nephrology|March 27, 2023
FGF-23 and sclerostin in serum and bone of CKD patientsFlorence Lima, Marie-Claude Monier-Faugere, Hanna Mawad, et al.
Biochemical and Biophysical Research Communications|February 19, 2008
PTH regulation of the human cytomegalovirus immediate-early gene promoterJohann Herberth, Alexander P Alimov, John P Williams, et al.
Clinical Nephrology|March 14, 2019
Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
Florence Lima, Hanna Mawad, Amr A El-Husseini, et al.
Journal of the American Society of Nephrology : JASN|May 23, 2000
High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantationMarie-Claude Monier-Faugere, Hanna Mawad, Quanle Qi, et al.
Journal of the American Society of Nephrology : JASN|December 24, 2011
Differences in bone quality in low- and high-turnover renal osteodystrophyHartmut H Malluche, Daniel S Porter, Marie-Claude Monier-Faugere, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Clinical Nephrology|October 6, 2022
Treatment of bone loss in CKD5D: Better survival in patients with non-high bone turnoverHartmut H Malluche, Daniel L Davenport, Marie-Claude Monier-Faugere, et al.
Endocrinology|June 18, 2003
Sp3/Sp1 in the parathyroid gland: identification of an Sp1 deoxyribonucleic acid element in the parathyroid hormone promoterAlexander P Alimov, M Chris Langub, Hartmut H Malluche, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 21, 2014
Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysisHartmut H Malluche, Daniel L Davenport, Tom Cantor, et al.
The Journal of Biological Chemistry|August 7, 2004
Suppression of the human parathyroid hormone promoter by vitamin D involves displacement of NF-Y binding to the vitamin D response elementNicholas J Koszewski, Alexander P Alimov, Ok-Kyong Park-Sarge, et al.
Clinical Nephrology|January 7, 2025
Kidney function, bone health, and vascular calcifications in patients with CKD II - IV: A 2 - 3 year prospective study with bone biopsiesHartmut H Malluche, Qi Qiao, Florence Lima, et al.
Clinical Nephrology|March 27, 2023
FGF-23 and sclerostin in serum and bone of CKD patientsFlorence Lima, Marie-Claude Monier-Faugere, Hanna Mawad, et al.
Biochemical and Biophysical Research Communications|February 19, 2008
PTH regulation of the human cytomegalovirus immediate-early gene promoterJohann Herberth, Alexander P Alimov, John P Williams, et al.
Clinical Nephrology|March 14, 2019
Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
Florence Lima, Hanna Mawad, Amr A El-Husseini, et al.
Journal of the American Society of Nephrology : JASN|May 23, 2000
High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantationMarie-Claude Monier-Faugere, Hanna Mawad, Quanle Qi, et al.
Journal of the American Society of Nephrology : JASN|December 24, 2011
Differences in bone quality in low- and high-turnover renal osteodystrophyHartmut H Malluche, Daniel S Porter, Marie-Claude Monier-Faugere, et al.
Pageof 7